key clinical trials in cll at ash 2020
Published 3 years ago • 70 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
8:04
key presentations in cll treatment at ash 2020
-
1:08
advances in cll at ash 2020: combination therapies
-
2:13
highlights in cll at ash 2020
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
6:43
key highlights in cll: clinical trial updates & the role of combination therapies and novel btkis
-
52:32
what is a clinical trial management system (ctms)?
-
5:00
venetoclax-obinutuzumab is superior to chemoimmunotherapy in frontline cll: updates from gaia/cll13
-
2:20
clinical trial updates in cml
-
0:45
key trials in cll and designing a concept for treatment
-
2:15
highlights in cll at ash and future research
-
2:09
cll highlights at ash 2020
-
2:46
significant cll trial updates to come at ash 2020
-
6:09
what were the cll highlights at ash 2020?
-
2:08
an insight into the current understanding of risk factors for cll
-
2:51
key btk inhibitor trials for the initial treatment of cll
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:19
updates in cml: recent trials and novel agents
-
3:21
long-term outcomes from key clinical trials presented at ash 2023
-
2:14
ongoing trials investigating the efficacy of pirtobrutinib in cll
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
0:48
real-world results in the uk for ibrutinib at first relapsed for mcl